Full Press Release Details
CAMBRIDGE, Mass., June 03, 2016 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading gene editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, will present at both the upcoming Jefferies 2016 Healthcare Conference and the 2016 International BIO Convention. Nessan Bermingham, PhD, Intellia’s Chief Executive Officer, will present on the company at Jefferies, and will participate in BIO’s next-generation Biotherapeutics panel session, “Gene Therapy or Gene Editing: Which one Will Change the Future of Medical Care?”
Jefferies 2016 Healthcare Conference
Date: Wednesday, June 8th
Location: Grand Hyatt, New York
Presentation Time: 10:00 am ET
A live webcast of the Jefferies presentation will be available on Intellia’s website at www.intelliatx.com under the Investor section. A replay of the session will be available for 90 days following the live event.
2016 International BIO Convention
Date: Thursday, June 9th
Next Generation Biotherapeutics Session
Location: Moscone Center, San Francisco, Room West 3006
Presentation Time: 9:00 am -10:15 am PT
About Intellia Therapeutics